PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsautoimmune thyroiditis
MeSH D013967 - autoimmune thyroiditis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D013966:Thyroiditis
$
Success rate
D001327:Autoimmune diseases
$
Success rate
D013967: 
Autoimmune thyroiditis
$
Success rate
D050031:Hashimoto disease
0 Companies
0 Drugs
Success rate
D050032:Postpartum thyroiditis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaLevothyroxine Levothyroxine  2020-10-28   
MylanLevothyroxine Ermeza 2035-02-27 2022-04-29   
Levothyroxine Levothyroxine  2002-06-05   
Lupin ResearchLevothyroxine Levothyroxine  2019-01-18   
AbbVieLevothyroxine Synthroid  2002-07-24 $767 M Y2021 
King PharmaceuticalsLevothyroxine Levoxyl 2022-02-15 2001-05-25   
Genus LifesciencesLevothyroxine Levolet 2038-03-23 2003-06-06   
Dr Reddys LaboratoriesLevothyroxine Levothyroxine  2020-03-27   
Zydus TherapeuticsLevothyroxine Levothyroxine  2023-03-24   
Amneal PharmaceuticalsLevothyroxine Levothyroxine  2019-02-19 $135.22 M Y2019 
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
33%
1/3
Phase 3
100%
2/2
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use